Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2019 Aug 24:126639. doi: 10.1016/j.bmcl.2019.126639. [Epub ahead of print]

Novel influenza polymerase PB2 inhibitors for the treatment of influenza A infection.

Author information

1
Center for AIDS Research, Global Virus Network, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
2
Center for AIDS Research, Global Virus Network, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: famblar@emory.edu.

Abstract

Exploration of the chemical space of known influenza polymerase PB2 inhibitor Pimodivir, was performed by our group. We synthesized and identified compounds 16a and 16b, two novel thienopyrimidine derivatives displaying anti-influenza A activity in the single digit nanomolar range in cell culture. Binding of these unique compounds in the influenza polymerase PB2 pocket was also determined using molecular modeling.

KEYWORDS:

Antiviral; Flu; Influenza A; Virus

PMID:
31493987
DOI:
10.1016/j.bmcl.2019.126639

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center